March 30, 2021 | 1:00 – 2:00pm EDT
ICH E6 (R3) is coming at a time when life science organizations still are struggling to adopt ICH E6 (R2). But should organizations wait until these guidelines are ratified to realize the intended benefits?
March 16, 2021 | 11:00am – 12:30pm EDT
Monthly forum open exclusively to AQC Members.
March 9, 2021 | 11:00am – 12:00pm EST
Held the second Tuesday of every month and open to the industry, this Webinar offers a live demonstration of the AQC Knowledge Center. No registration is required.
December 2-3, 2020 | Virtual
Join Avoca's session: "ICH E6(R3) Review: RBQM Considerations within Annex 2 Applied to Non-Traditional Trials"
October 14-15, 2020 | Virtual
Now in its ninth year, the Avoca Summit focuses on quality and the adoption of innovative technology in the execution of clinical trials.
Press Release – September 30, 2020 Novo Nordisk was recognized with the ACRP-Avoca Sponsor Quality Award during the ACRP-Avoca Quality Congress this month. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading sponsors at the event. The following ACRP-Avoca Sponsor Quality Awards were announced: First Place – Novo Nordisk Second Place […]
Read MorePress Release – September 30, 2020 Covance was recognized with the ACRP-Avoca CRO Quality Award during the ACRP-Avoca Quality Congress this month. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading CROs at the event. The following ACRP-Avoca CRO Quality Awards were announced: First Place – Covance Second Place – ICON […]
Read MoreInc. magazine today revealed that The Avoca Group has been placed on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. […]
Read More